EMBLAVEO

This brand name is authorized in Lithuania

Active ingredients

The drug EMBLAVEO contains a combination of these active pharmaceutical ingredients (APIs):

1 Aztreonam UNII G2B4VE5GH8 - AZTREONAM

Aztreonam exhibits activity in vitro against gram-negative aerobic pathogens, including P. aeruginosa. Aztreonam binds to penicillin-binding proteins of susceptible bacteria, which leads to inhibition of bacterial cell wall synthesis, followed by filamentation and cell lysis. Read about Aztreonam

2 Avibactam UNII 9V824P8TAI - AVIBACTAM SODIUM

Read about Avibactam

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EMBLAVEO Powder for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DF51		J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DF Monobactams
Discover more medicines within J01DF51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1099563